Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -10978.48% is 18% below its 5-year average of -9267.01%, near the high end of its 5-year range (-33297.70%–-1818.28%).
5.73% below its 12-month average of -10383.02%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -10899.52%.
NET PROFIT MARGIN
-10978.48%
NET PROFIT MARGIN AVG TTM
-10383.02%
NET PROFIT MARGIN AVG 3Y
-10116.11%
NET PROFIT MARGIN AVG 5Y
-9267.01%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.73%
CURRENT VS 3Y AVG
-8.52%
CURRENT VS 5Y AVG
-18.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-4222392.31%
vs the sector median at left
Aclarion, Inc.
Market Cap
$6.60M
Net Profit Margin
-10978.48%
TTM Avg
-10383.02%
3Y Avg
-10116.11%
5Y Avg
-9267.01%
Market Cap
$6.60M
Net Profit Margin
-1084.23%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.61M
Net Profit Margin
-84.79%
TTM Avg
-89.20%
3Y Avg
-105.63%
5Y Avg
-91.66%
Market Cap
$6.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.74M
Net Profit Margin
-611.47%
TTM Avg
-627.26%
3Y Avg
-917.71%
5Y Avg
-6297.45%
Market Cap
$6.88M
Net Profit Margin
0.00%
TTM Avg
-970.10%
3Y Avg
-487.29%
5Y Avg
1862.33%
Market Cap
$6.28M
Net Profit Margin
-534.27%
TTM Avg
-983.65%
3Y Avg
-1060.24%
5Y Avg
-924.37%
Market Cap
$7.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-287.91%
5Y Avg
-676.70%
Market Cap
$7.07M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.60M | -10978.48% | -10383.02% | -10116.11% | -9267.01% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | -1084.23% | 0.00% | 0.00% | 0.00% |
| Biomerica, Inc. (BMRA)vs › | $6.61M | -84.79% | -89.20% | -105.63% | -91.66% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | -611.47% | -627.26% | -917.71% | -6297.45% |
| Exicure, Inc. (XCUR)vs › | $6.88M | 0.00% | -970.10% | -487.29% | 1862.33% |
| Femasys Inc. (FEMY)vs › | $6.28M | -534.27% | -983.65% | -1060.24% | -924.37% |
| KALA BIO, Inc. (KALA)vs › | $7.04M | 0.00% | 0.00% | -287.91% | -676.70% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | 0.00% | 0.00% | -19.45% | -19.45% |
| Scienture Holdings, Inc. (SCNX)vs › | $6.11M | -4620.92% | -1491.69% | -1081.40% | -732.36% |
Operating Margin
-9312.5%
Net Profit Margin
-10978.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -10899.52% |
| 2026-03-31 | -13498.46% |
| 2025-12-31 | -10223.18% |
| 2025-09-30 | -9007.99% |
| 2025-06-30 | -8285.92% |
| 2025-03-31 | -10728.43% |
| 2024-12-31 | -19444.61% |
| 2024-09-30 | -9482.72% |
| 2024-06-30 | -11285.00% |
| 2024-03-31 | -23720.61% |
| 2023-12-31 | -9171.17% |
| 2023-09-30 | -5234.78% |
| 2023-06-30 | -8578.71% |
| 2023-03-31 | -4646.49% |
| 2022-12-31 | -5901.00% |
| 2022-09-30 | -8961.88% |
| 2022-06-30 | -33297.70% |
| 2022-03-31 | -10371.02% |
| 2021-12-31 | -26186.90% |
| 2021-09-30 | -27173.66% |
| 2021-06-30 | -1818.28% |
| 2021-03-31 | -4377.51% |
| 2020-12-31 | -5089.47% |
| 2020-09-30 | -10656.76% |
| 2020-06-30 | -10691.43% |
| 2020-03-31 | -10691.43% |
